COVID-19 has changed our lives in unprecedented ways over the past year. Here’s think back at where we were and where we go. The Centers for Disease Control and Prevention (CDC) revealed on February 20, 2020. That the first person in the United States to die from COVID-19 had died — a man in his fifties from Washington state.
According to the most recent data from Johns Hopkins University. Nearly 28 million Americans have infected with the novel (new) coronavirus, officially known as SARS-CoV-2. More than half a million people have died, more than in any other region.
With the advent of the first COVID-19 vaccines, the year has been one of unspeakable disaster, but also hope. According to Thomas Russo, MD, chief of infectious disease at the University of Buffalo Jacobs School of Medicine and Biomedical Sciences in New York. The creation of these highly efficient vaccines is “a great scientific tour de force.”
Here’s a look back at the most critical developments in the first year of the pandemic in the United States. Where we are now, and the challenges ahead.
In China, the Wuhan Municipal Health Commission reported the First Clusters of Pneumonia-Like Illness on December 31, 2019.
A cluster of pneumonia-like illnesses in Hubei Province, China, was reported to the World Health Organization (WHO) China Country Office on the last day of 2019. Officials are unable to pinpoint the outbreak’s source, and 44 people have become ill as of January 3, 2020.
Some patients work at the Huanan Seafood store, according to local authorities. The WHO would later describe the Huanan market as the coronavirus source. which is a “wet” market that sells live animals.
The CDC Confirmed the First Case of COVID-19 in the United States on January 21, 2020.
According to the CDC, a 35-year-old man from Washington state was the first person in the United States to test positive for the coronavirus six days after returning from Wuhan. In the United States, health authorities also don’t know anything about how the virus spreads. Still, the general opinion is that it applies mainly from animals to humans, with minimal human-to-human transmission.
The World Health Organization (WHO) officially names the virus on February 11, 2020.
The WHO names the virus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2 for short) and the disease it induces COVID-1. As infections spread primarily undetected in the United States.
The CDC Announced the First COVID-19 Death in the United States on February 20, 2020.
According to health officials, a man in his fifties from Washington state is the first person in the world to die of COVID-19. The man’s death confirmed by the CDC, along with another first COVID-19 is diagnosed. And hospitalized in a healthcare worker at a long-term care facility in the same state. A resident of the facility contracts the virus and is admitted to the hospital. Washington would soon become the United States’ first COVID-19 hotspot.
According to retroactive reports, two people in California died of COVID 19 weeks before, on February 6 and 17.
Cases in New York City are on the rise on March 23, 2020.
As COVID-19 cases rise, New York Governor Andrew Cuomo urges hospitals to increase capacity by 50%. New York City becomes the pandemic’s global epicenter. By the end of May, the city would have reported nearly 203,000 cases, with almost 10% of those resulting in death. With 260 deaths per 100,000 people, Latino New Yorkers are the hardest hit. Followed by Black New Yorkers with 248 deaths per 100,000 people. The COVID-19 mortality rate is 111 per 100,000 for Asian New Yorkers and 123 per 100,000 for white New Yorkers.
The United States became the global COVID-19 epicentre on March 26, 2020.
By the end of March, the United States had the highest number of COVID-19 cases and deaths of any country. According to data gathered by The New York Times, the CDC has reported over 81,000 cases and 1,000 deaths. Many more than in early epicentres such as China and Italy.
On 28 March 2020 the FDA approves emergency hydroxychloroquine in COVID-19 patients.
Despite a lack of evidence, Trump declares the malaria medication to be a miracle cure for COVID-19, an off-label use. After a comprehensive FDA–Center for Drug Assessment and Analysis study records serious issues related to heart arrhythmia, blood and lymph system disorders, kidney injuries, and liver failure, the US Food and Drug Administration (FDA) revoked the emergency use permit on June 15
The FDA approves the first COVID-19 vaccines for emergency use on December 11 and 18, 2020.
The FDA approved Pfizer’s two-dose vaccine for emergency use in people aged 16 and up on December 11. Clinical studies have shown that the vaccine has a 95% efficacy score, far beyond expectations. The FDA approves Moderna’s two-dose vaccine for people aged 18 and up a week later. With effectiveness equivalent to Pfizer’s vaccine.
Colorado reports the first case of a Coronavirus Variant from the United Kingdom in the United States on January 6, 2021.
This variant is more infectious as a result of viral mutations. Since the first cases of B.1.1.7 reported in Colorado in early January, we have found it in more than 500 patients across 33 states. A Minnesota Department of Health lab verified the first case of the P.1 version but originated in Brazil on January 25. South Carolina reports the first case of B.1.351, the South African version, three days later.
Johnson & Johnson releases safety and efficacy data for its COVID-19 vaccine on January 19, 2021
Early in March, the FDA is scheduled to approve the single-dose Johnson & Johnson vaccine for emergency use. Although it only prevents 66% of mild to COVID-19 severe cases, it tends to eliminate the possibility of hospitalization and death”The Johnson & Johnson data tends to be excellent in isolation. It will continue to play a vital role in ending the pandemic, says Dr. Russo of the University of Buffalo.
The number of Americans who have received a COVID-19 vaccine surpasses the total number of cases in the United States on February 2, 2021.
The Bloomberg Vaccine Tracker found that, for the first time, more Americans had received at least one dose of a COVID-19 vaccine than had contracted the virus by the beginning of February.
The FDA recommends a unique combination of monoclonal antibody therapy for urgent use on 9 February 2021.
The FDA has approved a combination of two monoclonal antibody drugs, bamlanivimab and etesevimab, to treat mild to moderate COVID-19 in patients aged 12 and up. Who at high risk of developing severe COVID-19 or admitted to the hospital. Researchers hope that doctors can have another tool in their arsenal against new coronavirus strains by combining these treatments.
The United States commemorates COVID-19 on February 20, 2021.
In the year after the CDC reported the first COVID-19 death in the United States, scientists’ perspectives on the disease have shifted dramatically. “It’s not just a respiratory infection, as we felt at first. Since the virus triggers inflammation and blood vessel disruption, virtually every organ in the body is affected”, says Russo. “Right now, we’re trying to figure out who’s in the hospital and dying and who isn’t, but I don’t think that’s the end of the story.”